Building
A Better
Tomorrow™
Tomorrow™
Our purpose is to build A Better Tomorrow™ by reducing the health impact of our business through offering a choice of less risky* products for our consumers. Science and innovation are accelerating our Tobacco Harm Reduction mission.
Focus
Our world-class scientists are generating evidence to support our New Category products. We are committed to making Tobacco Harm Reduction a reality.
Our world-class and transparent science means consumers can understand and trust in the performance, quality, and harm reduction potential of our products.
Research
We operate in a broad spectrum of scientific fields including molecular biology, toxicology and chemistry, and it is that breadth of expertise which fuels the relentless innovation and learning that sets us apart as an industry leader.
COVID-19
We are working on a potential vaccine for COVID-19
Publications
VapourOscar M. CamachoMay 2021Scientific Review Article Summary: A comprehensive evidence review of electronic cigarettes and their role in tobacco harm reduction
Tobacco Heating ProductsNathan GaleJuly 2021Changes in biomarkers after 180 days of tobacco heating product use: a randomised trial
Vapour & THPMichael McEwanMay 2021A randomized controlled study in healthy participants to explore the exposure continuum when smokers switch to a tobacco heating product or an E-cigarette relative to cessation
Insights
Director's ViewDr David O'Reilly shares his thoughts on science, COVID-19, and harm reduction
/
➜
➜
*Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.
Our products as sold in the US, including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.